💊 Varenicline (Varenicline)
Varenicline is a prescription medicine used as an aid to smoking cessation treatment. It acts at nicotinic receptors in the brain to help reduce craving and the reward from smoking. It should be used together with counseling and support.
In Arabic: فارينيكلين🏷️ Brand names & manufacturers
Packages shown are US-market (DailyMed). Brands available in Palestine are in the price section below.✅ What it is used for
- Aid to smoking cessation treatment
🧪 Active ingredient
The active substance is varenicline (as the tartrate salt), a partial nicotinic agonist selective for α4β2 nicotinic acetylcholine receptor subtypes; it binds to and stimulates the receptor at a lower level than nicotine while preventing nicotine binding.
🌿 Benefits
- Helps smoking cessation in patients motivated to quit when provided with appropriate advice and support
📝 How to use
- Taken orally after eating with a full glass of water
- Begin dosing one week before the patient's set quit date, or begin dosing and quit smoking between days 8 and 35 of treatment
- The dose is set by the doctor or pharmacist
💊 Dosage forms
- Tablets 0.5 mg
- Tablets 1 mg
⚠️ Common side effects
- Nausea
- Abnormal (vivid, unusual, or strange) dreams
- Constipation
- Flatulence
- Vomiting
🚨 Serious — seek medical help
- Changes in mood (including depression and mania)
- Psychosis, hallucinations, paranoia, delusions
- Aggression, hostility, agitation, anxiety, and panic
- Suicidal ideation, suicide attempt, and completed suicide
- New or worsening seizures
- Increased effects of alcohol
- Accidental injuries (e.g., traffic accidents)
- Cardiovascular events
- Somnambulism (sleepwalking)
- Angioedema and hypersensitivity reactions
- Serious skin reactions
⛔ Do not use if
- History of serious hypersensitivity reactions or skin reactions to varenicline
❗ Warnings & precautions
- Observe for serious neuropsychiatric symptoms; discontinue varenicline and contact a healthcare provider if they occur
- Use cautiously in patients with a history of seizures or other factors that can lower the seizure threshold
- Reduce alcohol consumption until you know whether varenicline affects you
- Use caution driving or operating machinery until you know how varenicline may affect you
- Notify your healthcare provider of new or worsening cardiovascular symptoms and seek immediate medical attention for signs of myocardial infarction or stroke
- Discontinue varenicline and notify your healthcare provider if somnambulism occurs
- Discontinue varenicline and immediately seek medical care if angioedema or hypersensitivity symptoms occur
🔄 Drug interactions
- No clinically meaningful pharmacokinetic drug interactions
- Safety and efficacy in combination with other smoking cessation therapies has not been established
- Coadministration with transdermal nicotine resulted in a high rate of discontinuation due to adverse events
- Smoking cessation may alter the pharmacokinetics or pharmacodynamics of certain drugs (e.g., theophylline, warfarin, insulin), possibly requiring dose adjustment
🤰 Pregnancy
Available data have not suggested an increased risk for major birth defects following exposure to varenicline in pregnancy compared with women who smoke. Smoking during pregnancy is associated with maternal, fetal, and neonatal risks. It is not known whether quitting smoking with varenicline during pregnancy reduces these risks.
🧒 Children
Varenicline is not recommended for use in pediatric patients 16 years of age or younger because its efficacy in this population was not demonstrated.
👴 Older adults
No overall differences in safety or effectiveness were observed between elderly and younger subjects, but greater sensitivity of some older individuals cannot be ruled out. No dosage adjustment is recommended for elderly patients; varenicline is substantially excreted by the kidney, and the risk of toxic reactions may be greater in patients with impaired renal function.
🌡️ Storage
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F).
🆘 Overdose
In case of overdose, standard supportive measures should be instituted as required. Varenicline has been shown to be dialyzed in patients with end-stage renal disease, however, there is no experience in dialysis following overdose.
💰 Price & brands in your area
Local prices are currently available for Palestine; more countries are coming. Ask your pharmacist for local price and alternatives.
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Varenicline binds with high affinity and selectivity at α4β2 neuronal nicotinic acetylcholine receptors; its efficacy in smoking cessation is believed to result from activity at this receptor subtype where binding produces agonist activity while simultaneously preventing nicotine binding to these receptors.
Labeled dosing
Begin dosing one week before the patient's set quit date, or begin dosing and quit between days 8 and 35. Starting week: 0.5 mg once daily on days 1 to 3 and 0.5 mg twice daily on days 4 to 7. Continuing weeks: 1 mg twice daily for a total of 12 weeks; an additional 12 weeks is recommended for successful quitters. Severe renal impairment (CrCl less than 30 mL/min): begin 0.5 mg once daily and titrate to 0.5 mg twice daily; in end-stage renal disease on hemodialysis, a maximum of 0.5 mg daily may be given if tolerated. Consider dose reduction for patients who cannot tolerate adverse effects.
- The dose is set by the doctor or pharmacist
- Provide patients with appropriate educational materials and counseling to support the quit attempt
- Take orally after eating with a full glass of water
- For patients unable or unwilling to quit abruptly, consider a gradual approach: reduce smoking by 50% from baseline within the first four weeks, by an additional 50% in the next four weeks, with the goal of complete abstinence by 12 weeks, and continue for an additional 12 weeks for a total of 24 weeks
- Another attempt at treatment is recommended for those who fail to stop smoking or relapse when contributing factors have been addressed
🎓 Key points for students
- Varenicline is a selective partial agonist at α4β2 nicotinic receptors
- Elimination half-life is approximately 24 hours
- 92% is excreted unchanged in the urine
- Plasma protein binding is low (≤20%)
- Absorption is virtually complete with systemic availability of ~90%
- Maximum plasma concentrations occur typically within 3 to 4 hours after oral administration
- Steady-state conditions are reached within 4 days
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is varenicline?
It is a medicine used as an aid to smoking cessation treatment that acts at nicotinic receptors in the brain.
How do I take varenicline?
Take it orally after eating with a full glass of water; the dose is set by your doctor or pharmacist.
Can varenicline cause serious neuropsychiatric effects?
Yes, reports include changes in mood, psychosis, hallucinations, and suicidal ideation; observe for these symptoms and discontinue and contact a healthcare provider if they occur.
Can I drive while taking varenicline?
Use caution driving or operating machinery until you know how varenicline may affect you, as accidental injuries have been reported.
Can varenicline be used in children?
It is not recommended for pediatric patients 16 years of age or younger because efficacy was not demonstrated.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2025-05), simplified. Updated: 2026-11-16.
Tyrvaya🏭 Harrow Eye, LLC
Varenicline Tartrate🏭 Lupin Pharmaceuticals, Inc.
Varenicline🏭 Aurobindo Pharma Limited
Varenicline🏭 Zydus Pharmaceuticals USA Inc.
Varenicline🏭 Zydus Lifesciences Limited